CT: A Primer on the Design and Conduct of Clinical Trials Using Biomarkers
Friday, September 17 2010
12:00 pm – 2:00 pm
Join us as we tackle issues like:
- What is the role of biomarkers in drug development?
- Biomarkers defined
- What value is added in using biomarkers
- Integration of biomarker development into the strategic drug development process - translation form animal models to human trials
- Safety and efficacy biomarkers that have impacted both the pre-clinical and clinical drug development process
- Response heterogeneity
- Integration of laboratory & clinical data in trial design
The panel will be chaired by Michelle Hylan, Halloran Consulting Group.
Panelists:
Lila Ramaiah, Veterinary Clinical Pathologist, Huntingdon Life Sciences
Peter Derrico, NED Biosystems
Monette Cotreau, Director, Clinical Pharmacology, Clinical Research, AVEO Pharmaceuticals
Francis Payumo, Senior Clinical Research Scientist, AVEO Pharmaceuticals
This meeting will take place at the MassBio offices, One Cambridge Center, Cambridge.
